Experience the future of T-cell research with Beckman Coulter Life Sciences.
As a global leader in laboratory automation and innovation, we are proud to introduce our latest breakthrough: the first commercially available anti-TRBC2 conjugated antibody.
Be among the first to test our TRBC1 and TRBC2 antibodies for your T-cell research
Identify clonal T-cell expansion with our TRBC1 and TRBC2 antibodies
This revolutionary development provides clinical researchers with unprecedented clarity in the identification of T-cell neoplasms, particularly in the field of cancer research.
Our TRBC1 and TRBC2 antibodies target the TCR constant β chains, which are randomly selected during T-cell development. Normal T-cell populations consist of a mix of TRBC1 and TRBC2, while clonal populations only contain one. By utilizing flow cytometry and our TRBC1 and TRBC2 conjugated antibodies, you can quickly and affordably perform a specific T-cell clonality test.
Don't miss out on this opportunity to revolutionize your T-cell research.
Sign up now for a FREE demo of our TRBC1 and TRBC2 antibodies and experience the future of T-cell clonality testing.
TRBC1 and TRBC2 are available through Custom Design Services either as a standalone conjugated antibody, or part of liquid or dry custom panel. For Research Use Only. Not for use in diagnostic procedures.